Sfoglia per Autore
Influence and variation of the body mass index (BMI) in patients treated with etanercept for plaque-type psoriasis
2007-01-01 Esposito, M; Mazzotta, A; Saraceno, R; Schipani, C; Bianchi, L; Chimenti, S
Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis
2007-01-01 Mazzotta, A; Esposito, M; Carboni, I; Schipani, C; Chimenti, S
Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients.
2007-01-01 Jakasa, I; Verberk, Mm; Esposito, M; Bos, Jd; Kezic, S.
Haplotypes associated with alleles of the immunoglobulin heavy chain enhancer HS1,2 of the 3¢ regulatory region in patients with psor- iatic arthritis
2008-01-01 Frezza, D; Esposito, M; Mattioli, C; Vaccari, G; Giambra, V; Chimenti, S; Bianchi, L.
Effect of anti tumor necrosis factor-alpha therapies on body composition in patients with psoriasis
2008-01-01 Saraceno, R; Schipani, C; Mazzotta, A; Esposito, M; Di Renzo, L; De Lorenzo, A; Chimenti, S
Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis
2008-01-01 Cianci, R; Giambra, V; Mattioli, C; Esposito, M; Cammarota, G; Scibilia, G; Magazzù G, ; Orlando, A; Sandri, G; Bianchi, L; Gasbarrini, Gb; Pandolfi, F; Frezza, D
Involvement of Ig heavy chain HS1,2-A enhancer*2 allele in dermatitis herpetiformis, plaque psoriasis and psoriatic arthritis
2008-01-01 Pandolfi, F; Cianci, R; Giambra, V; Mattioli, C; Esposito, M; Commarota, G; Scibilia, G; Maguzzu, G; Orlando, A; Lolli, S; Sandri, G; Bianchi, L; Frezza, D
Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis
2008-01-01 Saraceno, R; Schipani, C; Mazzotta, A; Esposito, M; Di Renzo, L; De Lorenzo, A; Chimenti, S
Etanercept at different dosages in the treatment of generalized pustular psoriasis: A case series
2008-01-01 Esposito, M; Mazzotta, A; Casciello, C; Chimenti, S
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis
2008-01-01 Esposito, M; Saraceno, R; Schipani, C; Di Marcantonio, D; Bianchi, L; Chimenti, S.
Long-term efficacy of etanercept in hidradenitis suppurativa.
2008-01-01 Zangrilli, A; Esposito, M; Mio, G; Mazzotta, A; Chimenti, S.
Dermatiti da piogeni o piodermiti
2009-01-01 Chimenti, S; Esposito, M; Bianchi, L
The therapeutic advantages on BMV plaster in chronic plaque psoriasis. Results from a new european multicentric study
2009-01-01 Esposito, M
Efficacy and Safety of Etanercept in Psoriasis after Switching from Other Treatments An Observational Study
2009-01-01 Mazzotta, A; Esposito, M; Costanzo, A; Chimenti, S
INFLUENCE AND VARIATION OF THE BODY MASS INDEX IN PATIENTS TREATED WITH ETANERCEPT FOR PLAQUE-TYPE PSORIASIS
2009-01-01 Esposito, M; Mazzotta, A; Saraceno, R; Schipani, C; Chimenti, S
Long-term experience with etanercept in psoriatic arthritis patients: A 3-year observational study
2009-01-01 Mazzotta, A; Esposito, M; Schipani, C; Chimenti, S
A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy
2009-01-01 Colombo, Gl; Di Matteo, S; Peris, K; Fargnoli, MARIA CONCETTA; Esposito, M; Mazzotta, A; Chimenti, S.
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis
2009-01-01 Caruso, R; Botti, E; Sarra, M; Esposito, M; Stolfi, C; Diluvio, L; Giustizieri, Ml; Pacciani, V; Mazzotta, A; Campione, E; Macdonald, Tt; Chimenti, S; Pallone, F; Costanzo, A; Monteleone, G
Psoriasis target therapy: ustekinumab
2010-01-01 Giunta, A; Esposito, M; Saraceno, S; Chimenti, S
CONTINUOUS TREATMENT OF PLAQUE-TYPE PSORIASIS WITH ETANERCEPT: AN OBSERVATIONAL LONG-TERM EXPERIENCE
2010-01-01 Esposito, M; Giunta, A; Mazzotta, A; Babino, G; Talamonti, M; Chimenti, Ms; Chimenti, S
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Influence and variation of the body mass index (BMI) in patients treated with etanercept for plaque-type psoriasis | 1-gen-2007 | Esposito, M; Mazzotta, A; Saraceno, R; Schipani, C; Bianchi, L; Chimenti, S | |
Clobetasol propionate foam 0.05% as a novel topical formulation for plaque-type and scalp psoriasis | 1-gen-2007 | Mazzotta, A; Esposito, M; Carboni, I; Schipani, C; Chimenti, S | |
Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients. | 1-gen-2007 | Jakasa, I; Verberk, Mm; Esposito, M; Bos, Jd; Kezic, S. | |
Haplotypes associated with alleles of the immunoglobulin heavy chain enhancer HS1,2 of the 3¢ regulatory region in patients with psor- iatic arthritis | 1-gen-2008 | Frezza, D; Esposito, M; Mattioli, C; Vaccari, G; Giambra, V; Chimenti, S; Bianchi, L. | |
Effect of anti tumor necrosis factor-alpha therapies on body composition in patients with psoriasis | 1-gen-2008 | Saraceno, R; Schipani, C; Mazzotta, A; Esposito, M; Di Renzo, L; De Lorenzo, A; Chimenti, S | |
Increased frequency of Ig heavy-chain HS1,2-A enhancer *2 allele in dermatitis herpetiformis, plaque psoriasis, and psoriatic arthritis | 1-gen-2008 | Cianci, R; Giambra, V; Mattioli, C; Esposito, M; Cammarota, G; Scibilia, G; Magazzù G, ; Orlando, A; Sandri, G; Bianchi, L; Gasbarrini, Gb; Pandolfi, F; Frezza, D | |
Involvement of Ig heavy chain HS1,2-A enhancer*2 allele in dermatitis herpetiformis, plaque psoriasis and psoriatic arthritis | 1-gen-2008 | Pandolfi, F; Cianci, R; Giambra, V; Mattioli, C; Esposito, M; Commarota, G; Scibilia, G; Maguzzu, G; Orlando, A; Lolli, S; Sandri, G; Bianchi, L; Frezza, D | |
Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis | 1-gen-2008 | Saraceno, R; Schipani, C; Mazzotta, A; Esposito, M; Di Renzo, L; De Lorenzo, A; Chimenti, S | |
Etanercept at different dosages in the treatment of generalized pustular psoriasis: A case series | 1-gen-2008 | Esposito, M; Mazzotta, A; Casciello, C; Chimenti, S | |
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis | 1-gen-2008 | Esposito, M; Saraceno, R; Schipani, C; Di Marcantonio, D; Bianchi, L; Chimenti, S. | |
Long-term efficacy of etanercept in hidradenitis suppurativa. | 1-gen-2008 | Zangrilli, A; Esposito, M; Mio, G; Mazzotta, A; Chimenti, S. | |
Dermatiti da piogeni o piodermiti | 1-gen-2009 | Chimenti, S; Esposito, M; Bianchi, L | |
The therapeutic advantages on BMV plaster in chronic plaque psoriasis. Results from a new european multicentric study | 1-gen-2009 | Esposito, M | |
Efficacy and Safety of Etanercept in Psoriasis after Switching from Other Treatments An Observational Study | 1-gen-2009 | Mazzotta, A; Esposito, M; Costanzo, A; Chimenti, S | |
INFLUENCE AND VARIATION OF THE BODY MASS INDEX IN PATIENTS TREATED WITH ETANERCEPT FOR PLAQUE-TYPE PSORIASIS | 1-gen-2009 | Esposito, M; Mazzotta, A; Saraceno, R; Schipani, C; Chimenti, S | |
Long-term experience with etanercept in psoriatic arthritis patients: A 3-year observational study | 1-gen-2009 | Mazzotta, A; Esposito, M; Schipani, C; Chimenti, S | |
A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy | 1-gen-2009 | Colombo, Gl; Di Matteo, S; Peris, K; Fargnoli, MARIA CONCETTA; Esposito, M; Mazzotta, A; Chimenti, S. | |
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis | 1-gen-2009 | Caruso, R; Botti, E; Sarra, M; Esposito, M; Stolfi, C; Diluvio, L; Giustizieri, Ml; Pacciani, V; Mazzotta, A; Campione, E; Macdonald, Tt; Chimenti, S; Pallone, F; Costanzo, A; Monteleone, G | |
Psoriasis target therapy: ustekinumab | 1-gen-2010 | Giunta, A; Esposito, M; Saraceno, S; Chimenti, S | |
CONTINUOUS TREATMENT OF PLAQUE-TYPE PSORIASIS WITH ETANERCEPT: AN OBSERVATIONAL LONG-TERM EXPERIENCE | 1-gen-2010 | Esposito, M; Giunta, A; Mazzotta, A; Babino, G; Talamonti, M; Chimenti, Ms; Chimenti, S |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile